US Stock MarketDetailed Quotes
JSPR Jasper Therapeutics
- 6.990
- -10.720-60.53%
Close Jan 8 16:00 ET
- 7.300
- +0.310+4.43%
Pre 06:18 ET
104.86MMarket Cap-1.47P/E (TTM)
9.730High6.810Low6.64MVolume8.740Open17.710Pre Close57.03MTurnover66.15%Turnover RatioLossP/E (Static)15.00MShares31.01052wk High1.25P/B70.16MFloat Cap6.81052wk Low--Dividend TTM10.04MShs Float188.800Historical High--Div YieldTTM16.49%Amplitude3.862Historical Low8.590Avg Price1Lot Size
Jasper Therapeutics Stock Forum
Sign in to post a comment
NOTE!
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
1. NFA (Not Financial Advice!)
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NE...
88
29
11
$Jasper Therapeutics (JSPR.US)$ Why the share price plummeted despite good progress in their research outcome?
$Jasper Therapeutics (JSPR.US)$
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
Wednesday, 8th January at 7:00 am
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile
Mean change in UAS7 from baseline of -26.6 observed in the 240mg single dose cohort at 8 weeks, multiple dosing regimens ≥120mg demonstrated UAS7 change of more than -25 points
100% (N=3) Com...
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
Wednesday, 8th January at 7:00 am
Rapid onset of deep and durable clinical responses observed across multiple dosing cohorts with a favorable safety profile
Mean change in UAS7 from baseline of -26.6 observed in the 240mg single dose cohort at 8 weeks, multiple dosing regimens ≥120mg demonstrated UAS7 change of more than -25 points
100% (N=3) Com...
1
big sell-off to trick people into selling, stock is going to Boom
$Jasper Therapeutics (JSPR.US)$ good time to buy back in cheap
$Jasper Therapeutics (JSPR.US)$ rise time, $15 by end of day
1
No comment yet
Heat List
US
Overall
Symbol
Price
% Chg
No Data
151158967 : Thank you, @Jaguar8 . Your hard work is appreciated!
103687630 : I think, what do you think of ONDS? There was good news on Wednesday but it went down. Do you think there is a chance for a rebound?
Jaguar8 OP 103687630 : I didn’t choose it because it didn’t specify how much is the contract.
103687630 Jaguar8 OP : Okay, thank you for your reply
70761249 : Can VERI make a breakthrough in the short term? The recent wildfires in Southern California are really heartbreaking, causing significant disappointment in the credibility of the media and government.
View more comments...